| OALBX0103 | A social network-based intervention increases HIV self-testing and linkage to health facilities among fishermen in Kenya | Oral abstract session with live Q&A | Population-specific interventions for HIV prevention |
| TUPEC06 | High prevalence rates of chlamydia and gonorrhea among adolescent men who have sex with men (AMSM) and transgender women (ATGW) enrolled in a PrEP cohort in Salvador, Northeast Brazil | Poster exhibition | Population-specific interventions for HIV prevention |
| TUPEC07 | Just how far off target are we? Measuring unmet pre-exposure prophylaxis (PrEP) need among men who have sex with men (MSM) and transgender women (TGW) in Asia | Poster exhibition | Population-specific interventions for HIV prevention |
| TUPEC08 | Accuracy of indirect adherence measures among adolescent men who have sex with men (aMSM) and transgender women (aTGW) in Brazil: a longitudinal analysis | Poster exhibition | Population-specific interventions for HIV prevention |
| TUPEC09 | A client-centered approach to eliminate mother-to-child transmission of HIV: outcomes from a large ART program in Kisumu County, Kenya | Poster exhibition | Population-specific interventions for HIV prevention |
| TUPEC10 | Adolescent PrEP initiation at clinics participating in a randomized trial of a standardized client actor training intervention in Kisumu, Kenya | Poster exhibition | Population-specific interventions for HIV prevention |
| EPA0094 | A panel of RBD-specific broadly neutralizing antibodies against SARS-CoV-2 variants | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0095 | Fc-modified HIV-1 broadly neutralizing monoclonal antibody, VRC01LS, shows enhanced biodistribution in human genital and rectal mucosal tissue compared to VRC01 | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0096 | COVID -19 vaccination uptake among adolescents and young people living with HIV in Kenya, 2021-2022 | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0097 | Comparison of immunogenicitiy and neutralizing antibody response of CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) between people living with HIV with CD4 ≤ 200/uL and CD4 >200 cells/uL | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |